Investing Profile

Kulika Weizman(358)

InvestorVCFormer CEO
General Partner at Creative Ventures
creativeventures.vcSan Francisco Bay Area
Photo of Kulika Weizman, General Partner at Creative Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture
Picture

10 Investors

Connected to Saar Gur (CRV), Brian Frank (FTW Ventures), Aaron Holiday (645 Ventures), and 7 other investors on Signal.

University of California, Berkeley Network
362 CONNECTIONS
University of Pennsylvania - The Wharton School Network
225 CONNECTIONS
University of Pennsylvania Network
219 CONNECTIONS
Siemens Network
29 CONNECTIONS
Penn Medicine Co-Investment Program Network
13 CONNECTIONS
cb
Creative Ventures General Partner
$500K - $1M
$750K
5
$50M
CompanyStageDateRound SizeTotal Raised
Rhaeos
Series AFeb 2023$11M
SeedDec 2021$2M
$13M
OncoPrecision
SeedAug 2022$3M
$3.9M
Co-investors: Po Bronson (SOSV), Sean O'Sullivan (SOSV), Alex Luce (Creative Ventures)
VenoStent
Seed Jan 2021$3M
$6M
Co-investors: Alex Luce (Creative Ventures)
Mobio Interactive
SeedSep 2020$2M
$2M
Investor Mobio InteractivePresent
Board Observer OncoPrecisionPresent
Board Observer RhaeosPresent
Board Member VenoStent, Inc.Present
Research Scientist BIOTECPresent
Co-founder & CEO SugarlogixPresent
Independent Consultant ASCB (American Society for Cell Biology)Present
Research Assistant University of Pennsylvania - Computer Science & Engineering DepartmentPresent
Graduate Student Researcher Energy Biosciences InstitutePresent
Emerging Technologies Investor SiemensPresent
General Partner Creative VenturesPresent
Board Observer VenoStent, Inc.Present
Board Observer Tierra BiosciencesPresent
Board Observer KOLIBRIPresent
Board Observer SYNVIVIAPresent
Board Observer NxLitePresent
Investor Cytonus TherapeuticsPresent
Principal Creative VenturesPresent
Senior Associate Creative VenturesPresent
Co-founder & CEO NAMUHPresent
Graduate Student Researcher Energy & Biosciences InstitutePresent
Independent Consultant American Society for Cell Biology (ASCB)Present
Research Assistant Penn Medicine Co-Investment ProgramPresent
CEO & Co-founder Sugarlogix2016 - 2018
University of Pennsylvania B.S. Chemical & Biomolecular Engineering
University of Pennsylvania - The Wharton School B.S. Economics
University of California, Berkeley Ph.D. Microbiology